RxDoctor Payments Data

Brent Cham

Internal Medicine · Houston, TXNPI 1265061600

Payments from drug & device makers

$2,958in general payments, 2019–2025

Across 88 payments — averaging $33.62 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Gilead$499
  • Sanofi$352
  • Astellas Pharma US Inc$208
  • Incyte Corporation$189
  • AstraZeneca$177
  • Bristol Myers Squibb$166
  • plus $1K from 18 others

What the payments were for

  • Food & beverage$2,62889%
  • Education$33111%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,958 in reported general payments places this provider in the 80th percentile of 7,675 internal medicine providers in Texas.

See all internal medicine providers in Texas

Other internal medicine in Houston

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →